Analyst Price Target is $11.55
▲ +21.20% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is $11.55, with a high forecast of $15.00 and a low forecast of $5.00. The average price target represents a 21.20% upside from the last price of $9.53.
Current Consensus is
The current consensus among 8 polled investment analysts is to buy stock in Hims & Hers Health. This Buy consensus rating has held steady for over two years.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.